Weili Ma

2.5k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Weili Ma is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Weili Ma has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Weili Ma's work include Cancer-related Molecular Pathways (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Weili Ma is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Weili Ma collaborates with scholars based in Taiwan, China and Canada. Weili Ma's co-authors include Samuel Benchimol, Yunping Lin, Razqallah Hakem, Daniel Y.L. Mao, Roger Leng, John M. Parant, Stephen W. Chung, Hong Wu, Bénédicte Lemmers and Guillermina Lozano and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Weili Ma

57 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation

2003 584 citations Roger Leng, Yunping Lin et al. Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Weili Ma	1.3k	986	348	186	149	59	2.0k
Hideki Murasawa	1.7k 1.3×	1.0k 1.0×	307 0.9×	252 1.4×	176 1.2×	13	2.2k
Ricardo Sánchez‐Prieto	1.3k 1.0×	696 0.7×	374 1.1×	153 0.8×	144 1.0×	74	2.1k
Kristina Viktorsson	1.5k 1.1×	637 0.6×	469 1.3×	139 0.7×	182 1.2×	70	2.2k
Tiziana Bruno	1.4k 1.0×	674 0.7×	337 1.0×	162 0.9×	144 1.0×	52	1.7k
Yunping Lin	1.6k 1.2×	1.1k 1.1×	411 1.2×	184 1.0×	159 1.1×	11	2.0k
Hilla Solomon	1.1k 0.8×	883 0.9×	551 1.6×	242 1.3×	108 0.7×	29	1.8k
Muthu Selvakumaran	1.3k 1.0×	745 0.8×	339 1.0×	233 1.3×	95 0.6×	31	1.9k
Isabella Manni	1.9k 1.4×	785 0.8×	494 1.4×	279 1.5×	218 1.5×	57	2.5k
Vladislava O. Melnikova	1.0k 0.8×	715 0.7×	522 1.5×	341 1.8×	167 1.1×	39	2.1k
Elżbieta Izbicka	2.1k 1.6×	748 0.8×	332 1.0×	122 0.7×	87 0.6×	96	3.1k

Countries citing papers authored by Weili Ma

Since Specialization

Citations

This map shows the geographic impact of Weili Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Ma more than expected).

Fields of papers citing papers by Weili Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Ma. The network helps show where Weili Ma may publish in the future.

Co-authorship network of co-authors of Weili Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Ma. A scholar is included among the top collaborators of Weili Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Ma. Weili Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guan, Le Luo, et al.. (2024). A Clinical-Radiomics Nomogram for Predicting Early Ischemic Stroke Risk in Patients with Transient Ischemic Attack. World Neurosurgery. 190. e199–e211. 1 indexed citations

Ma, Weili, Wang-Da Liu, Hsin‐Yun Sun, et al.. (2024). Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan. Journal of Microbiology Immunology and Infection. 57(3). 426–436. 2 indexed citations

Chen, I‐Chun, Ching‐Hung Lin, Dwan‐Ying Chang, et al.. (2024). Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer. Cell Reports Medicine. 6(1). 101879–101879. 3 indexed citations

Wang, Jianguo, et al.. (2024). Innovative Modeling of IMU Arrays Under the Generic Multi-Sensor Integration Strategy. Sensors. 24(23). 7754–7754. 1 indexed citations

Ma, Weili, et al.. (2024). Diagnostic role of F-18 FDG PET/CT in determining preoperative Lymph node status of patients with rectal cancer: a meta-analysis. Abdominal Radiology. 49(6). 2125–2134. 1 indexed citations

Ma, Weili, Ruey‐Long Hong, Pei‐Jen Lou, et al.. (2023). Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era. Cancer Medicine. 13(1). e6851–e6851. 1 indexed citations

Wu, Chun‐Yu, Yen‐Heng Lin, Yucheng Huang, et al.. (2023). Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes. Neurospine. 20(4). 1431–1442. 4 indexed citations

Cheng, Chieh‐Lung, Po‐Ting Yeh, Weili Ma, et al.. (2023). Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma. Cancer Medicine. 12(7). 8102–8111. 4 indexed citations

Ma, Weili, Dwan‐Ying Chang, Ching‐Hung Lin, et al.. (2022). Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices. The Oncologist. 27(12). 1008–1015. 2 indexed citations

10.

Fang, Dongping, et al.. (2022). Occurrence of ventricular septal perforation in patients with permanent left bundle branch pacing followed up using echocardiographic and computed tomography images. Annals of Noninvasive Electrocardiology. 27(6). e13002–e13002. 5 indexed citations

11.

Yao, Ming, Shu‐Lang Liao, Chung‐Wu Lin, et al.. (2022). First‐line antibiotic treatment in patients with localized extragastric mucosa‐associated lymphoid tissue lymphoma. SHILAP Revista de lepidopterología. 4(1). 55–66. 3 indexed citations

12.

Ma, Weili, Kun‐Huei Yeh, Ming Yao, et al.. (2020). Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas. Journal of the Formosan Medical Association. 120(1). 293–302. 5 indexed citations

13.

Ma, Weili, et al.. (2020). Efficacy of a programmed death‐1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2 . Dermatologic Therapy. 33(6). e14035–e14035. 1 indexed citations

14.

Ma, Weili, Chia‐Chi Lin, Feng‐Ming Hsu, et al.. (2019). Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study. Clinical Lung Cancer. 20(6). e609–e618. 7 indexed citations

15.

Ma, Weili, Hsin‐An Hou, Jih‐Luh Tang, et al.. (2016). Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Annals of Hematology. 95(4). 593–601. 42 indexed citations

16.

Wheaton, Keith, Yunping Lin, Weili Ma, et al.. (2011). ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress. Molecular Cell. 44(3). 491–501. 158 indexed citations

17.

Ma, Weili, Yunping Lin, Wanli Xuan, et al.. (2011). Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs. Oncogene. 31(8). 1024–1033. 12 indexed citations

18.

Lu, Jing, et al.. (2011). 4-[4-(1H-Tetrazol-5-yl)phenoxy]benzaldehyde. Acta Crystallographica Section E Structure Reports Online. 67(11). o3106–o3106. 2 indexed citations

19.

Leng, Roger, Yunping Lin, Weili Ma, et al.. (2003). Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation. Cell. 112(6). 779–791. 584 indexed citations breakdown →

20.

Lin, Yunping, Weili Ma, & Samuel Benchimol. (2000). Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis. Nature Genetics. 26(1). 122–127. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact